Collaborations Pharmaceuticals (United States)

241 papers and 7.3k indexed citations i.

About

In recent decades, authors affiliated with Collaborations Pharmaceuticals (United States) have published 241 papers, which have received a total of 7.3k indexed citations. Scholars at this organization have produced 109 papers in Computational Theory and Mathematics, 88 papers in Molecular Biology and 74 papers in Infectious Diseases on the topics of Computational Drug Discovery Methods (109 papers), Tuberculosis Research and Epidemiology (35 papers) and Pharmacogenetics and Drug Metabolism (33 papers). Their work is cited by papers focused on Computational Theory and Mathematics (2.9k citations), Molecular Biology (2.8k citations) and Infectious Diseases (1.4k citations). Authors at Collaborations Pharmaceuticals (United States) collaborate with scholars in United States, Brazil and Russia and have published in prestigious journals including Chemical Society Reviews, Journal of Biological Chemistry and Nature Materials. Some of Collaborations Pharmaceuticals (United States)'s most productive authors include Sean Ekins, Antony Williams, Matthew D. Krasowski, Alex M. Clark, Joel S. Freundlich, Kimberley M. Zorn, Thomas R. Lane, Daniel P. Russo, Valery Tkachenko and Ana C. Puhl.

In The Last Decade

Fields of papers published by authors at Collaborations Pharmaceuticals (United States)

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers affiliated with Collaborations Pharmaceuticals (United States) at the time of their publication. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers affiliated with Collaborations Pharmaceuticals (United States) at the time of their publication.

Countries citing scholars working at Collaborations Pharmaceuticals (United States)

Since Specialization

Citations

This map shows the geographic impact of research produced by authors working at Collaborations Pharmaceuticals (United States). It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at Collaborations Pharmaceuticals (United States) with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Collaborations Pharmaceuticals (United States) more than expected).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar’s output or impact.

Explore institutions with similar magnitude of impact

Breakdown of academic impact, for scholars at Indiana Cancer Consortium Breakdown of academic impact, for scholars at Pacific Coastal and Marine Science Center Breakdown of academic impact, for scholars at Fujirebio (Japan) Breakdown of academic impact, for scholars at Barclays (United Kingdom) Breakdown of academic impact, for scholars at Iceland GeoSurvey Breakdown of academic impact, for scholars at Malaria Consortium Breakdown of academic impact, for scholars at Nokia (United Kingdom) Breakdown of academic impact, for scholars at Solvay (Italy)